183 related articles for article (PubMed ID: 29167753)
41. [Virtual screening for components in Chicory combined with CNT2 target based on molecular docking].
Zhou Y; Zhang B; Lin ZJ; Zhang XM; Li F; Wang HG; Wang XJ
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):3962-3967. PubMed ID: 28929682
[TBL] [Abstract][Full Text] [Related]
42. Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.
Jaramillo AC; Hubeek I; Broekhuizen R; Pastor-Anglada M; Kaspers GJL; Jansen G; Cloos J; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1379-1388. PubMed ID: 32312148
[TBL] [Abstract][Full Text] [Related]
43. A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3.
Slugoski MD; Smith KM; Mulinta R; Ng AM; Yao SY; Morrison EL; Lee QO; Zhang J; Karpinski E; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2008 Sep; 283(36):24922-34. PubMed ID: 18621735
[TBL] [Abstract][Full Text] [Related]
44. Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.
Pérez-Torras S; Vidal-Pla A; Cano-Soldado P; Huber-Ruano I; Mazo A; Pastor-Anglada M
Cell Death Dis; 2013 May; 4(5):e648. PubMed ID: 23722537
[TBL] [Abstract][Full Text] [Related]
45. Cryo-EM structure of the human concentrative nucleoside transporter CNT3.
Zhou Y; Liao L; Wang C; Li J; Chi P; Xiao Q; Liu Q; Guo L; Sun L; Deng D
PLoS Biol; 2020 Aug; 18(8):e3000790. PubMed ID: 32776918
[TBL] [Abstract][Full Text] [Related]
46. Human Concentrative Nucleoside Transporter 3 (hCNT3, SLC28A3) Forms a Cyclic Homotrimer.
Stecula A; Schlessinger A; Giacomini KM; Sali A
Biochemistry; 2017 Jul; 56(27):3475-3483. PubMed ID: 28661652
[TBL] [Abstract][Full Text] [Related]
47. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
Ritzel MW; Yao SY; Ng AM; Mackey JR; Cass CE; Young JD
Mol Membr Biol; 1998; 15(4):203-11. PubMed ID: 10087507
[TBL] [Abstract][Full Text] [Related]
48. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
[TBL] [Abstract][Full Text] [Related]
49. Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectively.
Lai Y; Lee EW; Ton CC; Vijay S; Zhang H; Unadkat JD
Am J Physiol Cell Physiol; 2005 Jan; 288(1):C39-45. PubMed ID: 15456697
[TBL] [Abstract][Full Text] [Related]
50. In Silico Screening-Based Discovery of Novel Inhibitors of Human Cyclic GMP-AMP Synthase: A Cross-Validation Study of Molecular Docking and Experimental Testing.
Zhao W; Xiong M; Yuan X; Li M; Sun H; Xu Y
J Chem Inf Model; 2020 Jun; 60(6):3265-3276. PubMed ID: 32459092
[TBL] [Abstract][Full Text] [Related]
51. Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and corticotropin-releasing factor receptor 1 test cases.
Latek D
BMC Struct Biol; 2017 Aug; 17(1):8. PubMed ID: 28774292
[TBL] [Abstract][Full Text] [Related]
52. Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae.
Vickers MF; Young JD; Baldwin SA; Ellison MJ; Cass CE
Mol Membr Biol; 2001; 18(1):73-9. PubMed ID: 11396614
[TBL] [Abstract][Full Text] [Related]
53. Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation.
Rius M; Stresemann C; Keller D; Brom M; Schirrmacher E; Keppler D; Lyko F
Mol Cancer Ther; 2009 Jan; 8(1):225-31. PubMed ID: 19139132
[TBL] [Abstract][Full Text] [Related]
54. Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.
Smith KM; Ng AM; Yao SY; Labedz KA; Knaus EE; Wiebe LI; Cass CE; Baldwin SA; Chen XZ; Karpinski E; Young JD
J Physiol; 2004 Aug; 558(Pt 3):807-23. PubMed ID: 15194733
[TBL] [Abstract][Full Text] [Related]
55. Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.
Gloeckner-Hofmann K; Guillén-Gómez E; Schmidtgen C; Porstmann R; Ziegler R; Stoss O; Casado FJ; Rüschoff J; Pastor-Anglada M
Oncology; 2006; 70(3):238-44. PubMed ID: 16837820
[TBL] [Abstract][Full Text] [Related]
56. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
57. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
Gibbons GS; Chakraborty A; Grigsby SM; Umeano AC; Liao C; Moukha-Chafiq O; Pathak V; Mathew B; Lee YT; Dou Y; Schürer SC; Reynolds RC; Snowden TS; Nikolovska-Coleska Z
Eur J Med Chem; 2020 Mar; 189():112023. PubMed ID: 31978781
[TBL] [Abstract][Full Text] [Related]
58. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.
Farré X; Guillén-Gómez E; Sánchez L; Hardisson D; Plaza Y; Lloberas J; Casado FJ; Palacios J; Pastor-Anglada M
Int J Cancer; 2004 Dec; 112(6):959-66. PubMed ID: 15386342
[TBL] [Abstract][Full Text] [Related]
59. Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast.
Errasti-Murugarren E; Díaz P; Godoy V; Riquelme G; Pastor-Anglada M
Mol Pharmacol; 2011 Nov; 80(5):809-17. PubMed ID: 21825094
[TBL] [Abstract][Full Text] [Related]
60. Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.
Babu S; Nagarajan SK; Sathish S; Negi VS; Sohn H; Madhavan T
Front Pharmacol; 2022; 13():837369. PubMed ID: 35529449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
